Your Search Returned 28 tagged news reports
After breakfast, he's anxious to get to clients, so he speeds, or makes "jackrabbit" starts at green lights. Last week marked the anniversary of one of the worst Great Lakes shipping disasters. It was the Nov. 10, 1975, wreck of the Edmund Fitzgerald,...
Tags: Jason Mathers, corporations fleet, Abbott Laboratories, green driver, Chicago, Jamie Samsel, fuel efficiency, fleet managers, Woodridge, SmartWay Transport Partnership, Fuel economy in automobiles, Alternative propulsion, Fuel economy-maximizing behaviors, Fleet management, Environment, Business Finance
Cash green or blood red, depending on which company you talked to at this year's American Heart Association scientific meeting...The trial had its flaws, including that data was from just 208 patients, but Niaspan was the clear winner. When added to cholesterol-lowering...
Tags: cholesterol, niacin, new england journal of medicine, research, statins, drugs, Zetia, Merck & Co., Niaspan, Vytorin, Orlando, Ezetimibe/simvastatin, Ezetimibe, Merck & Co., Pharmaceutical industry, Abbott Laboratories, Schering-Plough, Pharmaceutical companies, Health Medical Pharma, Lipoproteins, High-density lipoprotein, Cardiology, Simvastatin, Atorvastatin, Business Finance, Rosuvastatin, Clopidogrel, Sanofi-Aventis, Thiophenes, Aspirin, Coronary artery bypass surgery, Antiplatelet drugs, Cardiovascular diseases
Bolstering its stable of drugs derived from human cells, Abbott Laboratories said Thursday that it will acquire the worldwide rights to an experimental pain drug from Dutch biotech firm PanGenetics BV for $190 million. Though still in early human clinical...
Tags: Abbott Laboratories, pain drug, PanGenetics BV, Netherlands, Amsterdam, Nicotinic agonists, Stimulants, German inventions, Analgesics, Opioids, Health Medical Pharma, Business Finance, Chronic pain, Back pain, Low back pain, Pain, Nociception, Symptoms
A former executive of failed U.S. energy company Enron's broadband subsidiary has been sentenced to 16 months in prison. Joseph Hirko, 53, who was co-chief executive officer of Enron Broadband Services, drew the sentence Monday from U.S.
Tags: Enron Broadband Services, Enron Corp., Joseph Hirko, chief executive, failed internet, energy giant, Joe Hirko, U.S, broadband network, Abbott Laboratories
6.6 billion purchase of Solvay 's pharmaceuticals business is just what the doctor ordered...Anti-inflammatory drug Humira makes up more than 17% of Abbott's sales, and being that dependent on one drug is very unhealthy. Sure, Humira is a biologic, which...
Tags: Abbott Laboratories, David Greising Abbott, Solvay Pharmaceuticals, Solvay Group, Solvay SA, pharmaceuticals business, Januvia
Treasury prices rose slightly Monday, extending recent gains even as investors moved back into stocks. The price of the benchmark 10-year note rose for a fifth straight day, adding 3/32 to 102 20/32. Its yield dipped to 3.31 percent from 3.32 percent...
Tags: Abbott Laboratories, jones industrials, stock futures, Xerox Corp., Dow Jones, corporate dealmaking, consumer confidence, industrials average, wall street, futures retreat
Abbott Laboratories is expected to announce as early as Monday the purchase of the pharmaceutical business of Belgian plastics and chemical giant Solvay SA for more than $6 billion in cash, according to sources close to the transaction.
Tags: Abbott Laboratories, Abbott Johnson & Johnson, Solvay SA, drug unit, buy solvay, Thomson Reuters, U.S, Reuters.com, billion euros, pharmaceuticals unit, Belgium, Brussels
Abbott Laboratories says results of a large study place its artery-opening Xience stent on equal footing with competitor Boston Scientific in diabetics, a difficult-to-treat group of patients. The company announced Wednesday there was no difference in...
In an attempt to bolster its fast-growing vascular business with new products to treat heart disease, Abbott Laboratories this afternoon announced plans to buy a maker of heart valve repair devices for more than $400 million. Abbott said it will make...
Tags: Abbott Laboratories, Abbott Labs, Evalve Inc., valve repair, heart valve, Evalve Co, repair devices
Abbott Laboratories will pay $400 million to acquire an eye-care device company specializing in technology used to treat patients with cataracts. North Chicago -based Abbott this afternoon said it plans to pay cash for Visiogen Inc., an Irvine, Calif.-based...
Tags: Abbott Laboratories, Visiogen Inc.